Semigran Marc
SEC insider (Form 3/4/5 filer). CIK 0001691494. Chief Development Officer at Edgewise Therapeutics, Inc. (EWTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Dec 24, 2024. Located in BOULDER, CO.
Companies Semigran Marc has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Officer, Chief Development Officer
Semigran Marc
CIK: 0001691494
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (66.7%)
Position reduction
Option Exercises (M)1 (33.3%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
EWTX
Edgewise Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Dec 24, 2024EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect29.7K shares at avg. $8.94$266K - Dec 24, 2024EWTX
Edgewise Therapeutics, Inc.
SaleDirect28K shares at avg. $29.66$830K - Dec 24, 2024EWTX
Edgewise Therapeutics, Inc.
SaleDirect1.7K shares at avg. $30.08$52K
1-3 of 3 transactions